0001816590-24-000040.txt : 20240227
0001816590-24-000040.hdr.sgml : 20240227
20240227172901
ACCESSION NUMBER: 0001816590-24-000040
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240223
FILED AS OF DATE: 20240227
DATE AS OF CHANGE: 20240227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Goldsmith George Jay
CENTRAL INDEX KEY: 0001843859
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39522
FILM NUMBER: 24688747
MAIL ADDRESS:
STREET 1: C/O COMPASS PATHWAYS PLC
STREET 2: 1 ASHLEY ROAD, 3RD FLOOR, ALTRINCHAM
CITY: CHESHIRE
STATE: X0
ZIP: WA14 2DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: COMPASS Pathways plc
CENTRAL INDEX KEY: 0001816590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3RD FLOOR, 1 ASHLEY ROAD
STREET 2: ALTRINCHAM
CITY: CHESIRE
STATE: X0
ZIP: WA14 2DT
BUSINESS PHONE: 1-716-676-6461
MAIL ADDRESS:
STREET 1: 3RD FLOOR, 1 ASHLEY ROAD
STREET 2: ALTRINCHAM
CITY: CHESIRE
STATE: X0
ZIP: WA14 2DT
FORMER COMPANY:
FORMER CONFORMED NAME: Compass Rx Ltd.
DATE OF NAME CHANGE: 20200701
4
1
wk-form4_1709072926.xml
FORM 4
X0508
4
2024-02-23
0
0001816590
COMPASS Pathways plc
CMPS
0001843859
Goldsmith George Jay
COMPASS PATHWAYS PLC
33 BROADWICK STREET
LONDON
X0
W1F 0DQ
UNITED KINGDOM
1
0
1
0
1
Ordinary Shares
2024-02-23
4
S
0
11863
10.0594
D
4112612
D
Ordinary Shares
2024-02-23
4
S
0
11862
10.0594
D
4110338
I
By: Spouse
Ordinary Shares
2024-02-26
4
S
0
17765
10.4476
D
4094847
D
Ordinary Shares
2024-02-26
4
S
0
17765
10.4476
D
4092573
I
By: Spouse
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Goldsmith on August 23, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.83 to $10.23, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
The reported sales occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Dr. Malievskaia on August 23, 2023.
Securities held by Dr. Ekaterina Malievskaia, the Reporting Person's spouse. Dr. Malievskaia and Mr. Goldsmith are married but they expressly disclaim beneficial ownership of each other's shares in the Issuer.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.23 to $10.735, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
/s/ Meredith Prithviraj by Power-of-Attorney for George Jay Goldsmith
2024-02-27